4.4 Article

The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic StudyS

Journal

DRUG METABOLISM AND DISPOSITION
Volume 50, Issue 2, Pages 158-167

Publisher

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/dmd.121.000640

Keywords

-

Funding

  1. National Institutes of Health National Institute of Drug Abuse [UG3 DA048353, UH3 DA048353, R01 DA047855]
  2. University of Florida Clinical and Translational Science Institute - National Institutes of Health National Center for Advancing Translational Sciences [UL1TR001427]
  3. University of Florida Foundation
  4. University of Florida Department of Pharmacodynamics Funding

Ask authors/readers for more resources

In this study, the analgesic effects, pharmacokinetics, and tissue distribution of Mitragynine (MTG) and its active metabolite 7hydroxymitragynine (7HMG) in mice were investigated. Results showed that 7HMG was more potent in producing analgesic effects compared to MTG, but as a metabolite of MTG, its brain concentration was significantly lower. Therefore, 7HMG has a negligible role in the analgesic effects of MTG.
Kratom (Mitragyna speciosa), a Southeast Asian tree, has been used for centuries in pain relief and mitigation of opium withdrawal symptoms. Mitragynine (MTG), the major kratom alkaloid, is being investigated for its potential to provide analgesia without the deleterious effects associated with typical opioids. Concerns have been raised regarding the active metabolite of MTG, 7hydroxymitragynine (7HMG), which has higher affinity and efficacy at m-opioid receptors than MTG. Here we investigated the hotplate antinociception, pharmacokinetics, and tissue distribution of MTG and 7HMG at equianalgesic oral doses in male and female C57BL/6 mice to determine the extent to which 7HMG metabolized from MTG accounts for the antinociceptive effects of MTG and investigate any sex differences. The mechanism of action was examined by performing studies with the opioid receptor antagonist naltrexone. A population pharmacokinetic/pharmacodynamic model was developed to predict the behavioral effects after administration of various doses of MTG and 7HMG. When administered alone, 7HMG was 2.8-fold more potent than MTG to produce antinociception. At equivalent effective doses of MTG and 7HMG, there was a marked difference in the maximum brain concentration of 7HMG achieved, i.e., 11-fold lower as a metabolite of MTG. The brain concentration of 7HMG observed 4 hours post administration, producing an analgesic effect <10%, was still 1.5-fold higher than the maximum concentration of 7HMG as a metabolite of MTG. These results provide strong evidence that 7HMG has a negligible role in the antinociceptive effects of MTG in mice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available